Inventor · disambiguated record
Kathryn Kamath
Also filed as: KAMATH KATHRYN · KAMATH KATHRYN VINAYA LOUISE · WEST JAMES W
22 granted patents·12 pending applications·797 citations·filing 2008–2024
97Inventor score
Files withCYTOMX THERAPEUTICS INC11SERIMMUNE INC10UNIV CALIFORNIA4STAGLIANO NANCY E3CYTOMX THERAPETUICS INC2
Top patents by PatentIndex Score
34 records- 0198US10875913B2Methods of treatment using activatable anti-EGFR antibodiesCYTOMX THERAPEUTICS INC·Filed 2018·Granted Dec 29, 2020·21 cites·40 claims
- 0298US10118961B2Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWVCYTOMX THERAPEUTICS INC·Filed 2016·Granted Nov 6, 2018·34 cites·13 claims
- 0398US10077300B2Activatable binding polypeptides and methods of identification and use thereofUNIV CALIFORNIA·Filed 2015·Granted Sep 18, 2018·42 cites·36 claims
- 0498US10059762B2Anti-EGFR activatable antibodiesCYTOMX THERAPEUTICS INC·Filed 2016·Granted Aug 28, 2018·42 cites·41 claims
- 0598US9644016B2Soluble notch receptor proproteins and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2015·Granted May 9, 2017·34 cites·28 claims
- 0698US8513390B2Modified antibody compositions, methods of making and using thereofSTAGLIANO NANCY E·Filed 2012·Granted Aug 20, 2013·111 cites·137 claims
- 0797US9169321B2Activatable binding polypeptides and methods of identification and use thereofUNIV CALIFORNIA·Filed 2013·Granted Oct 27, 2015·62 cites·41 claims
- 0897US8563269B2Modified antibody compositions, methods of making and using thereofSTAGLIANO NANCY E·Filed 2011·Granted Oct 22, 2013·119 cites·38 claims
- 0997US8529898B2Activatable binding polypeptides and methods of identification and use thereofDAUGHERTY PATRICK SEAN·Filed 2012·Granted Sep 10, 2013·64 cites·29 claims
- 1097US8399219B2Protease activatable interferon alpha proproteinSTAGLIANO NANCY E·Filed 2010·Granted Mar 19, 2013·46 cites·17 claims
- 1196US9453078B2Modified antibody compositions, methods of making and using thereofCYTOMX THERAPETUICS INC·Filed 2013·Granted Sep 27, 2016·64 cites·28 claims
- 1296US8993266B2Proproteins activatable interferon alphaCYTOMX THERAPEUTICS INC·Filed 2012·Granted Mar 31, 2015·28 cites·14 claims
- 1396US8518404B2Activatable binding polypeptides and methods of identification and use thereofDAUGHERTY PATRICK·Filed 2012·Granted Aug 27, 2013·105 cites·25 claims
- 1495US10513549B2Cleavage-activatable interferon-alpha proproteinCYTOMX THERAPEUTICS INC·Filed 2017·Granted Dec 24, 2019·14 cites·11 claims
- 1594US11028162B2Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moietiesUNIV CALIFORNIA·Filed 2018·Granted Jun 8, 2021·6 cites·27 claims
- 1692US10386373B2Methods and compositions for assessing antibody specificitiesSERIMMUNE INC·Filed 2018·Granted Aug 20, 2019·4 cites·28 claims
- 1790US12259396B2Methods and compositions for assessing antibody specificitiesSERIMMUNE INC·Filed 2024·Granted Mar 25, 2025·0 cites·30 claims
- 1890US2024228603A1Modified antibody compositions, methods of making and using thereofCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1987US12146884B2Methods and compositions for assessing antibody specificitiesSERIMMUNE INC·Filed 2023·Granted Nov 19, 2024·0 cites·27 claims
- 2085US2023183308A1Proproteins and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2184US2023375567A1Methods and compositions for assessing antibody specificitiesSERIMMUNE INC·Filed 2023·Application pending·0 cites
- 2283US10871494B2Methods and compositions for assessing antibody specificitiesSERIMMUNE INC·Filed 2019·Granted Dec 22, 2020·1 cites·30 claims
- 2381US2023035290A1Proproteins and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2479US12209120B2Activatable anti-VEGF scFvUNIV CALIFORNIA·Filed 2021·Granted Jan 28, 2025·0 cites·3 claims
- 2576US2021284721A1Modified antibody compositions, methods of making and using thereofCYTOMX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2675US11828762B2Methods and compositions for assessing antibody specificitiesSERIMMUNE INC·Filed 2020·Granted Nov 28, 2023·0 cites·28 claims
- 2774US2020308243A1Proproteins and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2868US2009304719A1Activatable binding polypeptides and methods of identification and use thereofDAUGHERTY PATRICK·Filed 2008·Application pending·0 cites
- 2966US2024192208A1Serum antibody profiling for leptospirosisSERIMMUNE INC·Filed 2023·Application pending·0 cites
- 3062US2013309230A1Modified Antibody Compositions, Methods of Making and Using ThereofCYTOMX THERAPETUICS INC·Filed 2013·Application pending·0 cites
- 3162US2023288421A1Sars-cov-2 serum antibody profilingSERIMMUNE INC·Filed 2022·Application pending·0 cites
- 3262US2021011025A1Methods and compositions for assessing antibody specificitiesSERIMMUNE INC·Filed 2016·Application pending·0 cites
- 3359US12297564B2Quality control reagents and methods for serum antibody profilingSERIMMUNE INC·Filed 2019·Granted May 13, 2025·0 cites·30 claims
- 3456US2010189651A1Modified antibody compositions, methods of making and using thereofCYTOMX THERAPEUTICS LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kathryn Kamath files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →